84 related articles for article (PubMed ID: 9308251)
1. Investigation of aberrant translational control of c-myc in cell lines derived from patients with multiple myeloma.
Willis AE; Paulin FE; West MJ; Whitney RL
Curr Top Microbiol Immunol; 1997; 224():269-76. PubMed ID: 9308251
[TBL] [Abstract][Full Text] [Related]
2. Aberrant translational control of the c-myc gene in multiple myeloma.
Paulin FE; West MJ; Sullivan NF; Whitney RL; Lyne L; Willis AE
Oncogene; 1996 Aug; 13(3):505-13. PubMed ID: 8760292
[TBL] [Abstract][Full Text] [Related]
3. Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.
Jernberg-Wiklund H; Pettersson M; Larsson LG; Anton R; Nilsson K
Int J Cancer; 1992 Apr; 51(1):116-23. PubMed ID: 1563831
[TBL] [Abstract][Full Text] [Related]
4. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
5. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
6. Selective expression of one c-myc allele in two human myeloma cell lines.
Kuehl WM; Brents LA; Chesi M; Bergsagel PL
Cancer Res; 1996 Oct; 56(19):4370-3. PubMed ID: 8813127
[TBL] [Abstract][Full Text] [Related]
7. A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors.
Paulin FE; Chappell SA; Willis AE
Nucleic Acids Res; 1998 Jul; 26(13):3097-103. PubMed ID: 9628905
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiation.
Greil R; Loidl P; Fasching B; Huber H
Curr Top Microbiol Immunol; 1992; 182():215-21. PubMed ID: 1490357
[No Abstract] [Full Text] [Related]
9. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
[TBL] [Abstract][Full Text] [Related]
10. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells.
Nobuyoshi M; Kawano M; Tanaka H; Ishikawa H; Tanabe O; Iwato K; Asaoku H; Sakai A; Kuramoto A
Br J Haematol; 1991 Apr; 77(4):523-8. PubMed ID: 2025578
[TBL] [Abstract][Full Text] [Related]
12. A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation.
Chappell SA; LeQuesne JP; Paulin FE; deSchoolmeester ML; Stoneley M; Soutar RL; Ralston SH; Helfrich MH; Willis AE
Oncogene; 2000 Sep; 19(38):4437-40. PubMed ID: 10980620
[TBL] [Abstract][Full Text] [Related]
13. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.
Greil R; Fasching B; Loidl P; Huber H
Blood; 1991 Jul; 78(1):180-91. PubMed ID: 2070052
[TBL] [Abstract][Full Text] [Related]
14. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
[TBL] [Abstract][Full Text] [Related]
15. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma.
Selvanayagam P; Blick M; Narni F; van Tuinen P; Ledbetter DH; Alexanian R; Saunders GF; Barlogie B
Blood; 1988 Jan; 71(1):30-5. PubMed ID: 3275475
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of c-myc in multiple myeloma.
Kuehl WM; Brents LA; Chesi M; Huppi K; Bergsagel PL
Curr Top Microbiol Immunol; 1997; 224():277-82. PubMed ID: 9308252
[TBL] [Abstract][Full Text] [Related]
17. Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.
Shi Y; Sun F; Cheng Y; Holmes B; Dhakal B; Gera JF; Janz S; Lichtenstein A
Mol Cancer Ther; 2022 Apr; 21(4):502-510. PubMed ID: 35086951
[TBL] [Abstract][Full Text] [Related]
18. Complex translocation disrupts c-myc regulation in a human plasma cell myeloma.
Hollis GF; Gazdar AF; Bertness V; Kirsch IR
Mol Cell Biol; 1988 Jan; 8(1):124-9. PubMed ID: 3275865
[TBL] [Abstract][Full Text] [Related]
19. Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation.
Mezquita P; Parghi SS; Brandvold KA; Ruddell A
Oncogene; 2005 Jan; 24(5):889-901. PubMed ID: 15580293
[TBL] [Abstract][Full Text] [Related]
20. Effects of interferon alpha on myeloma cells: mechanisms of differential responsiveness.
Jelinek DF; Arora T
Curr Top Microbiol Immunol; 1997; 224():261-8. PubMed ID: 9308250
[No Abstract] [Full Text] [Related]
[Next] [New Search]